Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3144 results

Sort By:

Spinal Stimulation With Gait Training to Improve Lower Limbs Motor Recovery in Spinal Cord Injury

Study ID: NCT07375745
Start Date: 2026-07-01
End Date: 2029-07
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

40

Intervention / Treatment

Protocol 1: Gait training combined with a sham stimulation

Protocol 2: Gait training combined with an effective tSCS

Sponsor

Centre for Interdisciplinary Research in Rehabilitation of Greater Montreal

Source: clinicaltrials.gov

Share:
Add to list

Phenol and Botulinum Toxin vs Botulinum Toxin Alone for Post-Stroke Upper-Limb Spasticity

Study ID: NCT07440173
Start Date: 2026-05-01
End Date: 2027-07-15
Study Type

Interventional

Study Phase

Phase4

No. of Participants

60

Intervention / Treatment

phenol neurolysis

Botulinum Toxin - A injections

Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

24-Month Trial of NPI-001 for the Preservation of Photoreceptors in Retinitis Pigmentosa Associated With Usher Syndrome

Study ID: NCT07290530
Start Date: 2026-06
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

80

Intervention / Treatment

N-acetylcysteine amide

Placebo

Sponsor

Nacuity Pharmaceuticals, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Adjustable Prosthetic Sockets

Study ID: NCT07397169
Start Date: 2026-06-15
End Date: 2029-08-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

25

Intervention / Treatment

Adjustable prosthetic socket

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

Ultrasound Scoring Methods to Monitor Breathing Problems in Intensive Care Patients

Study ID: NCT07446803
Start Date: 2026-03-15
End Date: 2026-04-15
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Abbreviated Lung Ultrasound Protocol

Sponsor

Clinical Hospital Center Rijeka

Source: clinicaltrials.gov

Share:
Add to list

Comparative Effectiveness of INTERCEPT Fibrinogen Complex (IFC) and Cryoprecipitate-AHF (Cryo-AHF) for Treatment of Trauma Associated Hemorrhage

Study ID: NCT07218185
Start Date: 2026-05
End Date: 2028-08
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

320

Intervention / Treatment

Pathogen Reduced Cryoprecipitated Fibrinogen Complex

Cryoprecipitated-Antihemophilic Factor

Sponsor

Cerus Corporation

Source: clinicaltrials.gov

Share:
Add to list

Clinical Study of How Information Flows Across the Human Cortical Sheet Layers (Laminae), Aiming to Discover Key Principles of Laminar Circuits and Information Flow for Complex Behavior.

Study ID: NCT07073391
Start Date: 2026-09-01
End Date: 2032-09-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Recording with laminar arrays

Sponsor

Christopher I. Petkov

Source: clinicaltrials.gov

Share:
Add to list

Evaluating the Ability of a Multi-Strain Postbiotic to Impact Inflammation, Immune Components, Gastrointestinal Symptoms, Recovery, Anxiety, and Intestinal Permeability

Study ID: NCT07387991
Start Date: 2026-06-01
End Date: 2027-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Multi-Strain Postbiotic

Placebo

Sponsor

Lindenwood University

Source: clinicaltrials.gov

Share:
Add to list

Clinical Safety Evaluation and Preliminary Efficacy Study of Subcutaneous Myografts Transplantation

Study ID: NCT07426068
Start Date: 2026-07-01
End Date: 2028-02-01
Study Type

Interventional

Study Phase

Early_phase1

No. of Participants

6

Intervention / Treatment

Autologous differentiated myocyte transplantation

Sponsor

National Clinical Research Center for Orthopedics, Sports Medicine and Rehabilitation, China

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1b/2 Open-label, Dose-ranging Safety and Efficacy Study of Oral Cladribine in Patients With Acute Myeloid Leukemia (AML)

Study ID: NCT07053020
Start Date: 2027-12-01
End Date: 2030-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

58

Intervention / Treatment

Cytarabine

Oral Cladribine

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list